Article Information
History
- November 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Georgina Ireland1,*,#,
- Heather Whitaker2,*,
- Shamez N Ladhani1,7,
- Frances Baawuah1,3,
- Vani Subbarao1,
- Ezra Linley4,
- Lenesha Warrener5,
- Michelle O’Brien3,
- Corinne Whillock1,
- Paul Moss6,
- Mary E Ramsay1,
- Gayatri Amirthalingam**,1 and
- Kevin E Brown**,1
- 1Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom
- 2Statistics, Modelling and Economics Department, UK Health Security Agency, London, United Kingdom
- 3Brondesbury Medical Centre, Kilburn, London, United Kingdom
- 4Sero-Epidemiology Unit, UK Health Security Agency, Manchester, United Kingdom
- 5Virus Reference Department, UK Health Security Agency, London, United Kingdom
- 6Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, United Kingdom
- 7Paediatric Infectious Diseases Research Group, St. George’s University of London, London, United Kingdom
- ↵#Correspondence: Georgina Ireland (Georgina.ireland{at}phe.gov.uk)
Posted November 24, 2021.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
8
Blogs/Media
Author Videos